Searched for
LA RENON
White Oak, Siguler Guff, Creador buy into La Renon PharmaAn investor consortium including White Oak Capital, Siguler Guff, and Creador has acquired approximately 10% of La Renon Healthcare for $1....- CCI approves proposed merger of Girnar group firms with Artivatic Data LabsFair trade regulator CCI has approved the merger of four Girnar group entities, including those operating CarDekho and InsuranceDekho, into...
- Creador to buy 7% stake in pharma company La RenonCreador, a Kuala Lumpur-based private equity firm, is set to acquire a 7% stake in La Renon Healthcare for ₹800 crore, valuing the Indian p...
- Avendus Fund, SBI Life lead funding in AragenAvendus Future Leaders Fund and SBI Life Insurance have collectively invested ₹300 crore in Aragen Life Sciences, acquiring a 2.5% stake in...
- A91 Partners on track to raise its largest fund at $700-750 millionA91 Partners, launched in 2018, debuted with a $350 million maiden fund. Just three years later, they scaled up significantly, securing $55...
- A91 Partners closes $665 million third fund, its largest yetFounded by former Sequoia Capital India (now Peak XV Partners) partners Abhay Pandey, VT Bharadwaj and Gautam Mago, A91 Partners focuses on...
- Avendus Future Leaders Fund picks minority stake in La Renon for Rs 160 croreAvendus Future Leaders Fund (FLF) has acquired a minority stake in Ahmedabad-based La Renon Healthcare for Rs 160 crore. This purchase mark...
- PE firms queue up for Novartis' Indian armThe PE firms are up against Dr Reddy's, which has an alliance with Novartis for marketing some of its off-patent products and is also expec...
- ChrysCapital sets sights on pharma buyout dealsChrysCapital, led by MD Kshitij Sheth, aims to acquire Indian companies in the formulation business with potential valuations of $200 milli...
- ChrysCap buys small stake in generics company La Renon for Rs 600 crIncorporated in 2007 by Pankaj Singh, La Renon is engaged in the manufacturing and marketing of branded generic formulations. ChrysCapital ...
- ChrysCapital close to acquiring 5-6% in pharma co La Renon HealthcareChrysCapital is close to acquiring 5-6% stake in La Renon Healthcare, a pharmaceutical company engaged in manufacturing and marketing of br...
- Goldman Sachs in talks to Invest Rs 1,600 crore in La Renon healthcareGoldman Sachs is reportedly planning to invest ₹1,600 crore ($200 million) in La Renon Healthcare in exchange for a significant stake. The ...
- Sequoia weighs La Renon Healthcare exitPlans are still on the drawing board and the storied Silicon Valley venture capitalist (VC) may not necessarily follow through with them, t...
- Pharma firm La Renon acquires majority stake in Enaltec LabsThis acquisition marks La Renon’s foray into the development, manufacturing and marketing of niche, specialised and complex active pharma i...
- Sun Pharmaceutical, Dr Reddy's Labs, JB Pharmaceuticals, Torrent Pharma and Piramal Pharma eye Oaknet HealthcareAnother mid-sized pharma firm, La Renon, backed by Sequoia Capital and A91 Partners is also keen on buying out Oaknet. Binding bids will be...
- La Renon raises $30 million from A91 Partners at $500 million valuationThe firm, which specialises in the chronic diseases segment, was valued at $100 million in 2015 when it received Rs 100 crore ($16 million ...
- With new reserves, Sequoia to become largest India-focussed VC fundSequoia is considering plans to raise about Rs 5,000 cr for a new fund, after it underlined its strategy for an aggressive pace of investme...
- Healthy dose: Sequoia Capital pumps in Rs 100 crore in La Renon HealthcareLa Renon expects to close the current financial year with topline of around Rs 325 crore with a target of reaching Rs 1,000 crore in the ne...
- Government clears FDI proposals of single-brand retailers like Mont Blanc, Forever and others worth Rs 281 croreForeign investment Promotion Board cleared Montblanc Services Blank B V, Netherlands and Titan Company’s proposal to set up JV for retailin...
- Government clears 21 FDI proposals worth Rs 281 croreThe FIPB has deferred 12 proposals including Mumbai-based Kotak Bank for increasing the foreign investment limit in the bank to 55 per cent.
Load More
